XOMA Co. (NASDAQ:XOMAO – Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 137 shares, a drop of 52.8% from the April 30th total of 290 shares. Based on an average trading volume of 7,344 shares, the short-interest ratio is currently 0.0 days.
XOMA Stock Down 0.0%
NASDAQ:XOMAO opened at $25.34 on Monday. The company has a 50-day moving average price of $25.45 and a 200-day moving average price of $25.42. XOMA has a 12 month low of $24.86 and a 12 month high of $26.40.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early?stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Recommended Stories
- Five stocks we like better than XOMA
- Alphabet Bets on Hardware With Googlebook and AI Glasses
- Burlington Beat Earnings Estimates, But Not Investor Expectations
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
